Michael G. Rosenblum

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.

J. Reuben, E. Hersh, M. Keating, 1985, The Journal of infectious diseases.

Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans.

G. Lopez-Berestein, R. Mehta, M. Rosenblum, 1984, Cancer drug delivery.

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.

R. Perez-soler, N. Donato, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.

D. Carlo, J. Murray, E. Hersh, 1985, Cancer research.

Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.

J. Murray, R. Benjamin, M. Rosenblum, 1985, Cancer research.

Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.

D. Carlo, J. Murray, E. Hersh, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer.

E. Hersh, G. Lopez-Berestein, T. Haynie, 1984, Cancer research.

Distribution and pharmacology of intravenous 99mTc-labeled multilamellar liposomes in rats and mice.

E. Hersh, K. Mehta, G. Lopez-Berestein, 1984, International journal of nuclear medicine and biology.

Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.

J. Murray, R. Benjamin, M. Rosenblum, 1988, Cancer research.